8 of 10 osteoarthritis patients experienced pain relief in Vioxx therapy

According to a recent survey of Advanced Arthritis Management (ADAM) conducted on osteoarthritis patients in Germany, about 8 of 10 patients said Vioxx (rofecoxib) therapy was better effective and prolonged duration of action in pain relief, compared with the typical NSAIDs regimen.

This survey was conducted by primary care doctors, including general practitioners, internal medicine doctors,...